Chronic activation of the JAK/STAT pathway in cancers promotes immune evasion, creates a pro-inflammatory environment, and drives tumor progression, affecting immune cells and distant sites such as lymph nodes and bone marrow [110]. Here, SOAT1 is linked to cancer.